EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*  by Arendrup, Maiken C. et al.
EUCAST technical note on the EUCAST
definitive document EDef 7.2: method for
the determination of broth dilution
minimum inhibitory concentrations of
antifungal agents for yeasts EDef 7.2
(EUCAST-AFST)*
Maiken C. Arendrup1, Manuel Cuenca-Estrella2,
Cornelia Lass-Flo¨rl3, William Hope4 and
the EUCAST-AFST*
1) Unit of Mycology, Department of Microbiological Surveillance and
Research, Statens Serum Institute, Copenhagen, Denmark, 2) Mycology
Reference Laboratory, National Center for Microbiology, Instituto de Salud
Carlos III, Majadahonda, Spain, 3) Division of Hygiene and Microbiology,
Innsbruck Medical University, Innsbruck, Austria and 4) The University of
Manchester, Manchester Academic Health Science Centre, NIHR,
Translational Research Facility in Respiratory Medicine, University Hospital
of South Manchester NHS Foundation Trust, Manchester, UK
Abstract
The European Committee on Antimicrobial Susceptibility Test-
ing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-
AFST) has revised the EDef 7.1 document on the method for
the determination of broth dilution minimum inhibitory concen-
trations of antifungal agents for fermentative yeasts. Changes
are: dimethylsulphoxide is now the recommended solvent for
caspofungin, micafungin and fluconazole; the shelf-life of plates
containing the echinocandins prepared from stock solutions in
dimethylsulphoxide is extended to 6 months at )80C; testing
of amphotericin and Cryptococcus has been incorporated; and
minimum inhibitory concentration ranges for quality control
strains and anidulafungin are included.
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This Technical Note is based on the EUCAST definitive document
EDef 7.2 (available at http://www.eucast.org/antifungal_susceptibility_
testing/methods_of_antifungal_susceptibility_testing/susceptibility_
testing_of_yeasts/).
The EUCAST Definitive Document EDef 7.1: method for the
determination of broth dilution MICs of antifungal agents for
fermentative yeasts was approved and published as a discus-
sion document (7.1) in 2003 [1] and the definitive document
was published in 2008 [2].
The European Committee on Antimicrobial Susceptibility
Testing–Subcommittee on Antifungal Susceptibility Testing
(EUCAST-AFST) has revised the document to reflect cur-
rent knowledge regarding the testing of non-fermentative
yeasts (most importantly Cryptococcus) and technical details
regarding MIC determinations for echinocandins and
amphotericin B. This Technical Note is based on the EU-
CAST definitive document EUCAST definitive document
EDef 7.2: Method for the determination of broth dilution mini-
mum inhibitory concentrations of antifungal agents for yeasts
(available on the EUCAST website: http://www.eucast.org).
In the full document the revised method is described in
detail.
Main updates are as follows. (i) Dimethylsulphoxide
(DMSO) is recommended as solvent for fluconazole and all
three echinocandins and shelf-life is extended to 6 months.
The motivation is that the commercially available fluconazole
pure substance and three echinocandins are hydrophobic,
that considerable variation in MICs has been demonstrated
when water is used as solvent, particularly for caspofungin,
and that susceptibility plates are stable at )80C for up to
6 months when DMSO is used [3]. (ii) For the time being it
is recommended that the RPMI 2% glucose is used also for
amphotericin B. The non-synthetic broth Antibiotic Medium
3 (AM3), supplemented to a final concentration of 2% glu-
cose, has been evaluated for detecting resistance to ampho-
tericin B [4–7]. However, there is batch-to-batch variation in
this medium, and also in the performance of the medium
from different manufacturers. (iii) Susceptibility testing of
Cryptococcus has been included. Main recommendations for
the time being are that the EUCAST methodology is adopted
and the plates are read when the optical density value is
>0.2. In cases with insufficient growth it is suggested that the
test be repeated but that trays are incubated at 30C [8].
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(iv) The following quality control MIC ranges have been
included for anidulafungin and Candida krusei ATCC 6258:
MIC £0.06 mg/L and for Candida parapsilosis ATCC 22019:
MIC range 0.25–1.0 mg/L.
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